Good news! Zhongsheng pharmaceutical special subject is listed in the national major science and technology special project of "major new drug creation"
-
Last Update: 2019-01-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, Zhongsheng pharmaceutical released a notice that its company recently received the notice on the second batch of projects for the implementation plan of major science and technology projects in 2018 of "major new drug creation" issued by the research center of medical and health science and technology development of the national health and Family Planning Commission (special letter of Health Science [2018] No 676), and the application of "zsp1601, a new chemical drug of class 1, for the treatment of nonalcoholic fatty hepatitis" Phase I / II clinical research, phase I / II clinical research on the treatment of idiopathic pulmonary fibrosis with zsp1603, a class I chemical new drug, and phase I / II clinical research on the treatment of advanced malignant tumors with zsp1602, a class I chemical new drug, have been included in the national major science and technology special project of "major new drug creation", as the second batch of project projects of 2018 new drug implementation plan The following is the original announcement:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
